African American/Black individuals have a disproportionate cancer burden, including the highest mortality and the lowest survival of any racial/ethnic group for most cancers. Every 3 years, the American Cancer Society estimates the number of new cancer cases and deaths for Black people in the United States and compiles the most recent data on cancer incidence (herein through 2018), mortality (through 2019), survival, screening, and risk factors using population-based data from the National Cancer Institute and the Centers for Disease Control and Prevention. In 2022, there will be approximately 224,080 new cancer cases and 73,680 cancer deaths among Black people in the United States. During the most recent 5-year period, Black men had a 6% higher incidence rate but 19% higher mortality than White men overall, including an approximately 2-fold higher risk of death from myeloma, stomach cancer, and prostate cancer. The overall cancer mortality disparity is narrowing between Black and White men because of a steeper drop in Black men for lung and prostate cancers. However, the decline in prostate cancer mortality in Black men slowed from 5% annually during 2010 through 2014 to 1.3% during 2015 through 2019, likely reflecting the 5% annual increase in advanced-stage diagnoses since 2012. Black women have an 8% lower incidence rate than White women but a 12% higher mortality; further, mortality rates are 2-fold higher for endometrial cancer and 41% higher for breast cancer despite similar or lower incidence rates. The wide breast cancer disparity reflects both later stage diagnosis (57% localized stage vs 67% in White women) and lower 5-year survival overall (82% vs 92%, respectively) and for every stage of disease (eg, 20% vs 30%, respectively, for distant stage). Breast cancer surpassed lung cancer as the leading cause of cancer death among Black women in 2019. Targeted interventions are needed to reduce stark cancer inequalities in the Black community.

中文翻译：

---

2022 年非裔美国人/黑人的癌症统计数据

非裔美国人/黑人个体有不成比例的癌症负担，包括大多数癌症的任何种族/族裔群体中最高的死亡率和最低的存活率。每 3 年，美国癌症协会估计美国黑人的新癌症病例和死亡人数，并汇编有关癌症发病率（截至 2018 年）、死亡率（截至 2019 年）、生存、筛查和使用来自国家癌症研究所和疾病控制与预防中心的基于人群的数据的风​​险因素。到 2022 年，美国黑人中将有大约 224,080 例新的癌症病例和 73,680 例癌症死亡。在最近的 5 年期间，黑人男性的发病率比白人男性高 6%，但死亡率比白人男性高 19%，包括大约 2 倍高的死于骨髓瘤、胃癌和前列腺癌的风险。由于黑人男性患肺癌和前列腺癌的人数急剧下降，黑人和白人男性之间的总体癌症死亡率差距正在缩小。然而，黑人男性前列腺癌死亡率的下降速度从 2010 年至 2014 年的每年 5% 降至 2015 年至 2019 年的 1.3%，这可能反映了自 2012 年以来晚期诊断的年增长率为 5%。黑人女性的死亡率下降了 8%发病率高于白人女性，但死亡率高出 12%；此外，尽管发病率相似或更低，但子宫内膜癌的死亡率高出 2 倍，乳腺癌的死亡率高出 41%。广泛的乳腺癌差异反映了晚期诊断（57% 局部阶段对白人女性 67%）和较低的 5 年总体生存率（分别为 82% 对 92%）和疾病的每个阶段（例如，20% 对30%，分别为远期）。2019 年，乳腺癌超过肺癌成为黑人女性癌症死亡的主要原因。需要有针对性的干预措施来减少黑人社区中严重的癌症不平等现象。